(Q55033133)

English

Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

scientific article published in June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

1 reference

based on heuristic

inferred from title

ulcerative colitis

1 reference

based on heuristic

inferred from title

Fernando Rizzello

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

Massimo Campieri

9

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

author name string

P Gionchetti

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

A Ferrieri

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

A Venturi

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

C Brignola

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

M Ferretti

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

S Peruzzo

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

M Miglioli

8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

44

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

1220-1221

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

https://scigraph.springernature.com/pub.10.1023/a:1026648812439

0 references

The efficacy of tobramycin in the treatment of ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10389700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic study of rifaximin after oral administration in healthy volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10389700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10389700

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1026648812439

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/10389700

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55033133&oldid=1520685455"